HELICOBACTER PYLORI INFECTION IN PATIENTS WITH CALCULAR CHOLECYSTITIS: A HOSPITAL BASED STUDY

Authors

  • Arshad Hussain Abro
  • Irfan Zafar Haider
  • Sarfraz Ahmad

Abstract

Background: Helicobacter pylori, a gram negative bacillus has been recognised as a public healthproblem and approximately half of the world population has H. pylori infection causes chronic gastritis,peptic ulcer disease and gastric malignancies. Objective of this study was to determine the frequency ofH. pylori infection in patients of chronic calcular cholecystitis. Methods: This cross-sectionaldescriptive study was conducted at Liaquat University Hospital, Hyderabad, Pakistan from April 2010 toSeptember 2010. All patients with history of gallstone presented with acute abdominal pain, dyspepsia,bloating and epigastric discomfort and diagnosed as calcular cholecystitis were further evaluated for thedetection of H. pylori by serology and histopathology. Frequency and percentage of H. pylori infectionin patients with calcular cholecystitis was calculated. Result: Total 100 patients of cholelithiasisunderwent laparoscopic cholecystectomy were recruited. The pain in upper right part of the abdomenwas observed in all 100 patients, fever in 75%, nausea and vomiting in 68%, loss of appetite in 45%,feeling of tiredness or weakness in 22%, headache in 38%, chills in 52%, backache in 58%, pain underthe right shoulder in 45%, heartburn in 67%, belching in 54%, indigestion in 80%, dyspepsia in 90%,bloating in 88%, and epigastric discomfort in 85% patients. Eighty-two percent patients had familyhistory of gallstones. The mean age of overall study population was 48.72±8.78 years and mean age ofH. pylori infected calcular cholecystitis patients was 47.98±5.43 years in male and 48.76±6.68 years infemales. The H. pylori infection was identified in 55% patients with calcular cholecystitis, of which32.7% were males and 67.3% were females (p=0.03, statistically significant). Majority of females (60%)had ≥40 U/ml antibody titre (p=0.917, non-significant). Conclusion: A possible relationship wasidentified between Helicobacter pylori and calcular cholecystitisKeywords: Gallstones, cholilithiasis, calcular cholecystitis, cholelithiatic cholecystitis, Helicobacterpylori

References

Huffman JL, Schenker S. Acute acalculous cholecystitis - a

review. Clin Gastroenterol Hepatol. Clin Gastroenterol Hepatol

;8(1):15–22.

Ballal M, Jyothi KN, Antony B, Arun C, Prabhu T, Shivananda

PG. Bacteriological spectrum of cholecystitis and its antibiogram.

Indian J Med Microbiol 2001;19:212–4.

Strasberg SM. Acute Calculous Cholecystitis. N Engl J Med

;358:2804–11.

Cho JY, Han HS, Yoon YS, Ahn KS. Risk factors for acute

cholecystitis and a complicated clinical course in patients with

symptomatic cholelithiasis. Arch Surg 2010;145(4):329–33.

Huang SM, Yao CC, Pan H, Hsiao KM, Yu JK, Lai TJ.

Pathophysiological significance of gallbladder volume changes in

gallstone diseases. World J Gastroenterol 2010;16(34):4341–7.

Girgin S, Gedik E, Taçyildiz IH, Akgün Y, Baç B, Uysal E.

Factors affecting morbidity and mortality in gangrenous

cholecystitis. Acta Chir Belg 2006;106:545–9.

Goodman KJ, Cockburn M. The role of epidemiology in

understanding the health effects of Helicobacter pylori.

Epidemology 2001;12:266–71.

Devrajani BR, Shah SZA, Soomro AA, Devrajani T. Type 2

diabetes mellitus: A risk factor for Helicobacter pylori infection: A

hospital based case-control study. Int J Diabetes Dev Ctries

;30:22–6.

Devrajani BR, Zaman SM, Shah SZA, Devrajani T, Lohana RK,

Das T. Helicobacter pylori: A Cause of Vitamin B12 Deficiency

(A Hospital Based Multidisciplinary Study). World Appl Sci J

;12:1378–81.

Devrajani BR, Devrajani T, Kumar R, Shah SZA, Memon AS.

Helicobacter pylori infection in cirrhotic patients with upper

gastrointestinal bleeding. World Appl Sci J 2010;8:137–40.

Queiroz DMM, Santos A, Oliveira AG, Rocha GA, Moura SB,

Camargo ERS, et al. Isolation of a Helicobacter strain from the

human liver. Gastroenterology 2001;121:1023–4.

Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL,

Sarmanho L, et al. Association of the presence of Helicobacter in

gall bladder tissue with cholelithiasis and cholecystitis. J Clin

Microbiol 2003;41:5615–8.

Mendez-Sanchez N, Pichardo R, Gonzalez J, Sanchez H, Moreno

M, Barquera F, et al. Lack of association between Helicobacter

species colonization and gall stone disease. J Clin Gastroenterol

;32:138–41.

Kawaguchi M, Saito T, Ohno H, Midorokawa S, Sanji T, Handa

Y, et al. Bacteria closely resembling Helicobacter pylori detected

immunohistologically and genetically in resected gall bladder

mucosa. J Gastroenterol 1996;31:294–8.

Apostolov E, Al Soud WA, Nilsson I, Kornilovska I, Usenko V,

Lyzogubov V, et al. Helicobacter pylori and other Helicobacter

species in gall bladder and liver of patients with chronic

cholecystitis detected by immunological and molecular methods.

Scand J Gastroenterol 2005;40(1):96–102.

Nilsson HO, Mulchandani R, Tranberg KG, Taneera J, Caastedal

M, Glatz E, et al. Helicobacter species identified in liver from

patients with cholangiocarcinoma and hepatocellular carcinoma.

Gastroenterology 2001;120:323–4.

Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation,

and the immune system in cholesterol gallstone formation.

Gastroenterology 2009;136:425–40.

Lu Y, Zhang BY, Shi JS, Wu LQ. Expression of the bacterial gene

in gallbladder carcinoma tissue and bile. Hepatobiliary Pancreat

Dis Int 2004;3:133–5.

Chen DF, Hu L, Yi P, Liu WW, Fang DC, Cao H. Helicobacter

pylori damages human gallbladder epithelial cells in vitro. World J

Gastroenterol 2008;14:6924–8.

Manoj P. Helicobacter species are associated with possible

increase in risk of biliary lithiasis and benign biliary diseases

World J Surg Oncol 2007,5:94–6.

Apostolov E, Al Soud WA, Nilsson I, Kornilovska I, Usenko V,

Lyzogubov V, et al. Helicobacter pylori and other Helicobacter

species in gall bladder and liver of patients with chronic

cholecystitis detected by immunological and molecular methods.

Scand J Gastroenterol 2005;40:96–102.

Deeba J, Sanjay S, Abida M, Athar K. Helicobacter pylori in gall

bladder disease. Biomed Res 2010;21:437–40.

Karagin PH, Stenram U, Wadström T, Ljungh A. Helicobacter

species and common gut bacterial DNA in gallbladder with

cholecystitis. World J Gastroenterol 2010;16:4817–22.

Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, et al.

Detection of Helicobacter pylori DNA in human biliary tree and

its association with hepatolithiasis. Dig Dis Sci 2000;45:1405–12.

Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, et

al. Most Helicobacter pylori infected patients have specific

antibodies and some also have H. pylori antigens and genomic

material in bile: is it a risk factor for gall stone formation? Dig Dis

Sci 1998;43:854–62.

Nilsson HO, Pietroiusti A, Gabrielli M, Zocco MA, Gasbarrini G,

Gasbarrini A. Helicobacter pylori and extragastric diseases--other

Helicobacters. Helicobacter 2005;10(Suppl 1):54–65.

Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard

MR, et al. Identification of cholelithogenic enterohepatic

helicobacter species and their role in murine cholesterol gallstone

formation. Gastroenterology 2005;128:1023–33.

Published

2011-03-01

Most read articles by the same author(s)